EVOF - 500

Evof – 500 Tablets FROM SOLACE BIOTECH

 
Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class and is the S (-) enantiomer

of the racemic drug substance ofloxacin.

Composition

Each film-coated tablet contains:

Levofloxacin Hemihydrate

equivalent to Levofloxacin 500 mg

Indications

Treatment of acute maxillary sinusitis,

Lower respiratory tract infections,

Skin and skin structure infections,

Urinary tract infections,

Acute pyelonephritis and prostatitis.

Dosage and Administration

For the treatment of Acute maxillary sinusitis, acute bacterial exacerbations of chronic bronchitis, or

community-acquired pneumonia in adults : 500 mg every 24 hours.

Uncomplicated skin and skin structure infections: 500 mg every 24 hours

Complicated skin and skin structure infections : 750 mg every 24 hours.

Uncomplicated urinary tract infection, complicated urinary tract infections, or acute pyelonephritis :

250 mg every 24 hours.

The duration of levofloxacin therapy depends on the type and severity of infection and should be

determined by the clinical and bacteriologic response of the patient. Acute maxillary sinusitis usually

requires 10-14 days of therapy.

Acute bacterial exacerbations of chronic bronchitis require 7 days;

Community-acquired pneumonia or complicated skin and skin structure infections require 7-14 days of

therapy.

For uncomplicated skin and skin structure infections, the usual duration of levofloxacin therapy is 7-10

days.

Uncomplicated urinary tract infections require 3 days of therapy;

Complicated urinary tract infections and acute pyelonephritis usually require 10 days of therapy. Or

As directed by the physician.

CONTRAINDICATIONS:

Hypersensitivity to Levofloxacin , other quinolones or any of the ingredients in this product

PREGNANCY AND LACTATION:

Levofloxacin tablets are contraindicated in pregnancy and lactation.

PRESENTATION

1 Blister of 5 Tablets, each is packed in a Carton

LUVENT LC

Luvent-LC Tablets

is a combination of Montelukast Sodium & Levocetirizine

Dihydrochloride.

Montelukast sodium is a selective and orally active leukotriene receptor

antagonist that inhibits the cysteinyl leukotriene CysLT

1 receptor.

Levocetirizine, the R-enantiomer of cetirizine, is a potent and selective antagonist

of peripheral H1-receptors.

It has been demonstrated by recent studies that the treatment of Allergic Rhinitis with

concomitant administration of an antileukotriene (montelukast) and an

antihistamine (levocetirizine), shows significantly better symptom relief compared

with the modest improvement of rhinitis symptomatology with each of the

treatments alone.

http://www.solacebiotech.in/other-files/anti-allergic-anti-asthmatic.pdf